In the News

26 July, 2024

COVID-19 Won't Raise Odds For Chronic Fatigue Syndrome: Study

COVID-19 doesn’t raise a person’s risk of developing chronic fatigue syndrome more than any other infectious disease, a new study finds. The rate of chronic fatigue syndrome following a brief illness was roughly the same between people who caught COVID and those who came down with some other malady, researchers reported July 24 in the journal JAMA Network Open.

26 July, 2024

Study Finds Limited Evidence For Massage Therapy's Effectiveness In Pain Relief

A recent study published in JAMA Network Open reviews evidence to determine whether massages effectively relieve pain.

26 July, 2024

If You're Feeling Tired All The Time You Might Actually Have A Common Condition

Chronic fatigue syndrome, also known as myalgic encephalomyelitis (ME), has been in the news a lot recently as many people in the UK have experienced it as a result of a viral infection such as coronavirus.

25 July, 2024

Breakthrough Study: Anarti's Ayurvedic CBD Oil Shows Promising Results For Fibromyalgia And Chronic Pain Relief

Anarti Therapeutics is proud to announce promising data from an in vitro study conducted at the Dabur Research Foundation. The study's results demonstrate a possible biologic mechanism of action for how Anarti Therapeutics' Ayurvedic CBD Relief Oil helps relieve chronic pain associated with fibromyalgia.

25 July, 2024

Long COVID & ME/CFS: The Similarities Are Uncanny

An estimated two million people in England and Scotland were experiencing symptoms of long COVID as of March 2024, according to the Office for National Statistics. Of these, 1.5 million said the condition was adversely affecting their day-to-day activities. As more research emerges about long COVID, some experts are noticing that its trigger factors, symptoms, and causative mechanisms overlap with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

25 July, 2024

Hidden Connection Discovered: New Research Links Brain Inflammation To Muscle Fatigue

Researchers at Washington University have discovered that brain inflammation can cause muscle dysfunction by releasing a protein that travels to the muscles, impairing their function. In experiments with fruit flies and mice, they found that this protein reduces energy production in muscle mitochondria. The research also identified possible ways to block this process, which could help treat or prevent muscle wasting in conditions like bacterial infections, Alzheimer’s, and long COVID.

24 July, 2024

NHS Treatment For ME Patients To Be Examined

A lack of NHS treatment for people with myalgic encephalomyelitis (ME) is set to be interrogated at an inquest into the death of a 27-year-old woman, who died after being discharged from hospital. Maeve Boothby-O’Neill died in October 2021, after battling myalgic encephalomyelitis – also referred to as chronic fatigue syndrome (CFS) – for more than half her life, until she was no longer able to eat or drink. She faced barriers to receiving proper care right up until her death as she tried to convince doctors her illness was real – which her parents say also caused delays in her receiving end-of-life care. A long-awaited government delivery plan to improve NHS services has been beset by delays since being unveiled by Sajid Javid two years and three health secretaries ago.

24 July, 2024

NHS Wards Not Capable Of Treating ME Patients, Expert Tells Exeter Inquest

A leading ME expert has told an inquest there is still no hospital ward in England capable of managing patients with the illness, and said it was a “travesty” that some medical professionals did not believe it was a real physical condition.

24 July, 2024

What Makes It Tick: Exploring The Mechanisms Of Post-Treatment Lyme Disease Syndrome

Post-treatment Lyme disease syndrome (PTLDS), which may also be referred to incorrectly as "chronic Lyme disease," is defined by the Infectious Diseases Society of America (IDSA) as the presence of fatigue, pain, and/or cognitive complaints with the functional impact that persists for more than six months after completing treatment for Lyme disease (LD). These symptoms occur in 10%-20% of patients previously diagnosed with LD caused by the bacteria Borrelia burgdorferi and appropriately treated with a course of antibiotics. The symptoms of PTLDS can be easily overlooked or misdiagnosed as a psychiatric manifestation in geographic locations that rarely see LD. In contrast, geographic locations with a higher prevalence of LD may be more aware of PTLDS symptoms and have higher clinical suspicion leading to this diagnosis. The pathophysiology behind the persistent symptoms some people experience from a primary infection is still largely unknown. Some mechanisms that have been proposed include permanent tissue damage and inflammation, immune system dysfunction, autoimmune response, co-infection, and even persistent infection refractory to treatment. We propose that ongoing PTLDS symptoms seem to be related to an autoimmune response to the tissue damage and inflammation caused by the viable or nonviable spirochete pathogen. At this point, PTLDS is diagnosed clinically as no quantifiable methods are available from laboratory or tissue diagnostics as of 2024. Similar pathophysiological features of PTLDS are seen in diseases such as COVID-19 or chronic fatigue syndrome (CFS). More effective diagnostic approaches might include further studies looking at a possible connection in the genomes of individuals developing PTLDS, quantifiable biomarkers, common inflammatory markers/pathways, and careful histopathological studies of human tissues.

23 July, 2024

A Place In The Sun (British TV Show)

Danni Menzies is house-hunting on the beautiful island of Lanzarote with Richard and Catherine from Essex. They're eager to find a permanent family home in the sun that will offer daughter Jessica, who has chronic fatigue syndrome, and the whole family a better quality of life. They love the area around Playa Blanca, so Danni takes their budget of £300,000 to line up some tempting options.